Article
Deciphering the underlying mechanism of Xianlinggubao capsule against osteoporosis by network pharmacology
3 Jul 2020
Abstract excerpt
BACKGROUND: Xianlinggubao formula (XLGB), a Chinese State Food and Drug Administration-permitted traditional Chinese herbal medicine, has been extensively used to treat osteoporosis. Although XLGB was shown to improve bone mass in ovariectomized rats and clinically alleviate osteoporosis symptoms, its pharmacological mechanisms remain unclear. METHODS: In this study, we used a network pharmacological approach to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
